Levetiracetam ameliorates ovarian function in streptozotocin-induced diabetic rats

References

• Mamoulakis D, Galanakis E, Bicouvarakis S, et al. Epidemiology of childhood type I diabetes in Crete, 1990–2001. Acta Paediatr 2003;92:737–9
   PubMed Web of Science ®Google Scholar
• Karvonen M, Pitkäniemi J, Tuomilehto J. The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes Care 1999;22:1066–70
   PubMed Web of Science ®Google Scholar
• Gale EA, Gillespie KM. Diabetes and gender. Diabetologia 2001;44:3–15
   PubMed Web of Science ®Google Scholar
• Codner E, Merino PM, Tena-Sempere M. Female reproduction and type 1 diabetes: from mechanisms to clinical findings. Hum Reprod Update 2012;18:568–85
   PubMed Web of Science ®Google Scholar
• Kjaer K, Hagen C, Sandø SH, Eshøj O. Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to controls. J Clin Endocrinol Metab 1992;75:524–9
   PubMed Web of Science ®Google Scholar
• Schweiger BM, Snell-Bergeon JK, Roman R, et al. Menarche delay and menstrual irregularities persist in adolescents with type 1 diabetes. Reprod Biol Endocrinol 2011;9:61–8
   PubMed Web of Science ®Google Scholar
• Isik S, Ozcan HN, Ozuguz U, et al. Evaluation of ovarian reserve based on hormonal parameters, ovarian volume, and antral follicle count in women with type 2 diabetes mellitus. J Clin Endocrinol Metab 2012;97:261–9
   PubMed Web of Science ®Google Scholar
• van den Oever IA, Raterman HG, Nurmohamed MT, Simsek S. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators Inflamm 2010;2010:792393. doi: 10.1155/2010/792393
   PubMed Web of Science ®Google Scholar
• De Smedt T, Raedt R, Vonck K, Boon P. Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug. CNS Drug Rev 2007;13:57–78
   PubMedGoogle Scholar
• Stettner M, Dehmel T, Mausberg AK, et al. Levetiracetam exhibits protective properties on rat Schwann cells in vitro. J Peripher Nerv Syst 2011;16:250–60
   PubMed Web of Science ®Google Scholar
• Ueda Y, Doi T, Takaki M, et al. Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: in vivo evaluation by brain microdialysis combined with ESR spectroscopy. Brain Res 2009;1266:1–7
   PubMed Web of Science ®Google Scholar
• Gibbs JE, Walker MC, Cock HR. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus. Epilepsia 2006;47:469–78
   PubMed Web of Science ®Google Scholar
• Coppey LJ, Davidson EP, Dunlap JA, et al. Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve. Int J Exp Diabetes Res 2000;1:131–43
   PubMedGoogle Scholar
• Erbaş O, Yeniel AÖ, Akdemir A, et al. The beneficial effects of levetiracetam on polyneuropathy in the early stage of sepsis in rats: electrophysiological and biochemical evidence. J Invest Surg 2013;26:312–18
   PubMed Web of Science ®Google Scholar
• Demougeot C, Marie C, Beley A. Importance of iron location in iron-induced hydroxyl radical production by brain slices. Life Sci 2000;67:399–410
   PubMed Web of Science ®Google Scholar
• Benzie IF, Strain JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999;299:15–27
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70–7
   PubMed Web of Science ®Google Scholar
• Kjaer K, Hagen C, Sandø SH, Eshøj O. Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to controls. J Clin Endocrinol Metab 1992;75:524–9
   PubMed Web of Science ®Google Scholar
• Yeshaya A, Orvieto R, Dicker D, et al. Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. Int J Fertil Menopausal Stud 1995;40:269–73
   PubMed Web of Science ®Google Scholar
• Codner E, Merino PM, Tena-Sempere M. Female reproduction and type 1 diabetes: from mechanisms to clinical findings. Hum Reprod Update 2012;18:568–85
   PubMed Web of Science ®Google Scholar
• Chang AS, Dale AN, Moley KH. Maternal diabetes adversely affects preovulatory oocyte maturation, development, and granulosa cell apoptosis. Endocrinology 2005;146:2445–53
   PubMed Web of Science ®Google Scholar
• Chabrolle C, Jeanpierre E, Tosca L, et al. Effects of high levels of glucose on the steroidogenesis and the expression of adiponectin receptors in rat ovarian cells. Reprod Biol Endocrinol 2008;6:11–24
   PubMed Web of Science ®Google Scholar
• Powers RW, Chambers C, Larsen WJ. Diabetes-mediated decreases in ovarian superoxide dismutase activity are related to blood-follicle barrier and ovulation defects. Endocrinology 1996;137:3101–10
   PubMed Web of Science ®Google Scholar
• Griffin ML, South SA, Yankov VI, et al. Insulin-dependent diabetes mellitus and menstrual dysfunction. Ann Med 1994;26:331–40
   PubMed Web of Science ®Google Scholar
• Poretsky L, Kalin MF. The gonadotropic function of insulin. Endocr Rev 1987;8:132–41
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Piperi C, Patsouris E, et al. Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem Cell Biol 2007;127:581–9
   PubMed Web of Science ®Google Scholar
• Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008;57:1446–54
   PubMed Web of Science ®Google Scholar
• Ramasamy R, Vannucci SJ, Yan SSD, et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005;15:16–28
   PubMed Web of Science ®Google Scholar
• Tan AL, Forbes JM, Cooper ME. Age, RAGE, and ROS in diabetic nephropathy. Semin Nephrol 2007;27:130–43
   PubMed Web of Science ®Google Scholar
• Zeh HJ, Lotze MT. Addicted to death: invasive cancer and the immune response to unscheduled cell death. J Immunother 2005;28:1–9
   PubMed Web of Science ®Google Scholar
• Ban CR, Twigg SM. Fibrosis in diabetes complications: pathogenic mechanism and circulating and urinary markers. Vasc Health Risk Manag 2008;4:575–96
   PubMedGoogle Scholar
• Kuhad A, Chopra K. Attenuation of diabetic nephropathy by tocotrienol: involvement of NF-kB signaling pathway. Life Sci 2009;84:296–301
   PubMed Web of Science ®Google Scholar
• Mezzano S, Aros C, Droguett A, et al. NF-kB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transpl 2004;19:2505–12
   PubMed Web of Science ®Google Scholar
• Cameron NE, Cotter MA. Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway. Curr Drug Targets 2008;9:60–7
   PubMed Web of Science ®Google Scholar
• Svalheim S, Taubøll E, Surdova K, et al. Long-term levetiracetam treatment affects reproductive endocrine function in female Wistar rats. Seizure 2008;17:203–9
   PubMed Web of Science ®Google Scholar
• Taubøll E, Gregoraszczuk EL, Tworzydlo A, et al. Comparison of reproductive effects of Levetiracetam and valproate in prepubertal porcine ovarian follicular cells. Epilepsia 2006;47:1580–3
   PubMed Web of Science ®Google Scholar
• Gustavsen MW, von Krogh K, Taubøll E, et al. Differential effects of antiepileptic drugs on steroidogenesis in a human in vitro cell model. Acta Neurol Scand Suppl 2009;18:14–21
   Google Scholar
• Taubøll E, Gregoraszczuk EL, Wojtowicz AK, Milewicz T. Effects of levetiracetam and valproate on reproductive endocrine function studied in human ovarian follicular cells. Epilepsia 2009;50:1868–74
   PubMed Web of Science ®Google Scholar
• Rauchenzauner M, Bitsche G, Svalheim S, et al. Effects of levetiracetam and valproic acid monotherapy on sex-steroid hormones in prepubertal children–results from a pilot study. Epilepsy Res 2010;88:264–8
   PubMed Web of Science ®Google Scholar
• Svalheim S, Taubøll E, Luef G, et al. Differential effects of levetiracetam, carbamazepine, and lamotrigine on reproductive endocrine function in adults. Epilepsy Behav 2009;16:281–7
   PubMed Web of Science ®Google Scholar
• Marini H, Costa C, Passaniti M, et al. Levetiracetam protects against kainic acid-induced toxicity. Life Sci 2004;74:1253–64
   PubMed Web of Science ®Google Scholar
• Oliveira AA, Almeida JP, Freitas RM, et al. Effects of levetiracetam in lipid peroxidation level, nitrite-nitrate formation and antioxidant enzymatic activity in mice brain after pilocarpine-induced seizures. Cell Mol Neurobiol 2007;27:395–406
   PubMed Web of Science ®Google Scholar
• Zapater P, Moreno J, Horga JF. Neuroprotection by the novel calcium antagonist PCA50938, nimodipine and flunarizine, in gerbil global brain ischemia. Brain Res 1997;772:57–62
   PubMed Web of Science ®Google Scholar